Board of Directors

Kan Chen, Ph.D.

Dr. Chen is a Principal of Qiming Venture Partners, focusing on healthcare investment. Before joining Qiming Venture Partners, Dr. Chen was a senior scientist at Johnson & Johnson, where he focused on cancer medicine. Prior to that, Dr. Chen was a group leader at Jiangsu Hengrui Medicine, where he specialized in cancer immunotherapies. Dr. Chen … Read more

James Z. Huang, MBA

Mr. Huang has over 30 years of biotech experience and he is the Founding Partner of Panacea Venture, an investment firm with its focus on innovative and transformative healthcare and life sciences companies worldwide. Mr. Huang served as managing partner at Kleiner Perkins (KPCB) China and Vivo Ventures, and he served in various leadership roles … Read more

Jean Liu, J.D.

Ms Liu is a senior executive with more than 25 years of biopharmaceutical and legal firm experience and currently Executive Vice President, Legal Affairs, General Counsel and Secretary of Seagen Inc., a targeted cancer therapeutic company. She previously served in senior legal leadership roles at Halozyme Therapeutics, Inc. and Durect Corporation, including General Counsel, Head … Read more

Wubin (Bill) Pan, Ph.D., MBA

Dr. Pan is a co-founder of Connect and has served as President and Chairman of the Board of Directors since May 2012. He has over 25 years of experience in biopharmaceutical R&D, including 10 years in Europe and North America. Prior to co-founding Connect, Dr. Pan co-founded and led Crown Bioscience Inc., a U.S. venture-backed company … Read more

Barry Quart, Pharm.D.

Dr. Barry Quart brings over 30 years of extensive experience serving in leadership positions in biotechnology and pharmaceutical companies and developing innovative pharmaceutical products. He has personally led several early-stage biotech companies through late-stage clinical development, regulatory strategy, highlighted by nine U.S. Food and Drug Administration (FDA) approved drugs. Dr. Quart was most recently CEO … Read more

Karen J. Wilson, CPA

Ms. Wilson is a strategic biopharmaceutical finance executive and board member with more than 30 years of industry and leadership experience in life science companies across finance, strategy and risk management.  She is currently an independent Director and Chairperson of the Audit Committee for Elicio Therapeutics (ELTX) (formerly Angion Biomedica) and LAVA Therapeutics (LVTX). She … Read more

Kleanthis G. Xanthopoulos, Ph.D. (Chairman)

Dr. Xanthopoulos has over  24 years of experience in the biotechnology and pharmaceutical research industries as an executive, company founder, chief executive officer, investor and board member. Dr. Xanthopoulos is currently Chairman & CEO of Shoreline Biosciences, and Chairman of Stork Capital Life Sciences, which focuses on building and investing in innovative biotechnology companies. He … Read more

Zheng Wei, Ph.D.

Dr. Zheng has served as CEO and a member of our board of directors since he co-founded the company in 2012. He has over 25 years of biopharmaceutical industry experience in the autoimmune disease and inflammation therapeutic areas. Prior to co-founding Connect, Dr. Zheng was Director of Immunology at Arena Pharmaceuticals where he oversaw its … Read more